19.00
price down icon5.28%   -1.06
after-market Dopo l'orario di chiusura: 19.36 0.36 +1.89%
loading
Precedente Chiudi:
$20.06
Aprire:
$19.27
Volume 24 ore:
138.93K
Relative Volume:
0.16
Capitalizzazione di mercato:
$75.73M
Reddito:
-
Utile/perdita netta:
$-24.77M
Rapporto P/E:
-26.03
EPS:
-0.73
Flusso di cassa netto:
$-17.36M
1 W Prestazione:
-18.28%
1M Prestazione:
+156.06%
6M Prestazione:
+103.30%
1 anno Prestazione:
+108.75%
Intervallo 1D:
Value
$18.54
$20.00
Intervallo di 1 settimana:
Value
$18.54
$24.00
Portata 52W:
Value
$4.5601
$76.00

Mink Therapeutics Inc Stock (INKT) Company Profile

Name
Nome
Mink Therapeutics Inc
Name
Telefono
212-994-8250
Name
Indirizzo
149 FIFTH AVENUE, NEW YORK
Name
Dipendente
23
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-13
Name
Ultimi documenti SEC
Name
INKT's Discussions on Twitter

Confronta INKT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
INKT
Mink Therapeutics Inc
19.00 79.95M 0 -24.77M -17.36M -0.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-07-14 Downgrade William Blair Outperform → Mkt Perform

Mink Therapeutics Inc Borsa (INKT) Ultime notizie

pulisher
Jul 24, 2025

What analysts say about MiNK Therapeutics Inc. stockExplosive market performance - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 23, 2025

MiNK Therapeutics Inc. Stock Analysis and ForecastConsistent triple returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

What drives MiNK Therapeutics Inc. stock priceUnprecedented profits - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 22, 2025

Is MiNK Therapeutics Inc. a good long term investmentFree Investment Timing Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

(INKT) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Jul 22, 2025
pulisher
Jul 22, 2025

How MiNK Therapeutics Inc. stock performs during market volatilityRisk Managed Trading Strategy - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

MiNK Therapeutics (NASDAQ:INKT) Upgraded at B. Riley - Defense World

Jul 21, 2025
pulisher
Jul 18, 2025

MiNK Therapeutics Announces Clinical Trial Success - MSN

Jul 18, 2025
pulisher
Jul 17, 2025

MiNK Therapeutics Stock Surges on Breakthrough Testicular Cancer Remission and iNKT Cell Therapy Progress - Oncodaily

Jul 17, 2025
pulisher
Jul 17, 2025

MiNK Therapeutics (NASDAQ:INKT) Rating Lowered to “Neutral” at HC Wainwright - Defense World

Jul 17, 2025
pulisher
Jul 17, 2025

Mink Therapeutics Shares Slide After Announcing $50 Million Stock Offering - MSN

Jul 17, 2025
pulisher
Jul 17, 2025

MiNK Therapeutics (NASDAQ:INKT) Cut to Neutral at HC Wainwright - Defense World

Jul 17, 2025
pulisher
Jul 16, 2025

Mink Therapeutics stock tumbles on $50 million stock offering - Investing.com

Jul 16, 2025
pulisher
Jul 15, 2025

Agenus unit, MiNK surges after peer-reviewed data for lead drug - MSN

Jul 15, 2025
pulisher
Jul 15, 2025

What makes MiNK Therapeutics Inc. stock price move sharplyAI Powered Stock Call - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why MiNK Therapeutics Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics stock rating downgraded to Neutral by H.C. Wainwright - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Plummets 29%—What’s Driving the Sell-Off? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Plummets 28.59% — What’s Driving the Sell-Off? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Mink Therapeutics stock tumbles on $50 million stock offering By Investing.com - Investing.com Nigeria

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics publishes research on CAR-iNKT cell therapy By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics enters $50 million at-the-market sales agreement with B. Riley Securities By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics enters $50 million at-the-market sales agreement with B. Riley Securities - Investing.com Canada

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Publishes Peer-Reviewed Article Highlighting Innovations in CAR-iNKT Cell Therapies for Solid Tumors - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Announces Frontiers in Immunology - GlobeNewswire

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Announces Frontiers in Immunology Publication Highlighting iNKT Cells as a Dual-Function Platform Key to Overcoming Barriers in Solid Tumor Cell Therapy - TradingView

Jul 15, 2025
pulisher
Jul 15, 2025

Revolutionary iNKT Cell Therapy Achieves 2-Year Complete Remission in Treatment-Resistant Cancer - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics tumbles after $50 mln stock offering filing - TradingView

Jul 15, 2025
pulisher
Jul 15, 2025

INKT’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Enters $50M Sales Agreement with B. Riley - TipRanks

Jul 15, 2025
pulisher
Jul 15, 2025

MiNK Therapeutics Plunges 24.87% After William Blair Downgrade - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

INKT sets up $50M ATM with B. Riley, adds financing flexibility | INKT SEC FilingForm 8-K - Stock Titan

Jul 15, 2025

Mink Therapeutics Inc Azioni (INKT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):